{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-24-000076","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.094506+00:00","generated_at":"2026-05-30T10:47:01.476569+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Dentsply Sirona suspends Byte aligner sales after FDA consult; Q3 rev ~$951M, impairment up to $550M","bullets":["Voluntarily suspends sale/marketing of Byte aligners and impression kits in consultation with FDA.","Byte represents ~5% of annual revenue; suspension expected to materially impact operations.","Prelim Q3 net sales ~$951M; adjusted EPS guided $0.49-$0.51 (non-GAAP).","Expects $450-$550M non-cash goodwill impairment (net of tax) for Orthodontic Aligner and Implant reporting units.","Q3 sales benefited by ~$20M shift of distributor orders from Q4 due to ERP implementation."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-24-000076","json":"https://secwatch.observer/filing/0000818479-24-000076.json","markdown":"https://secwatch.observer/filing/0000818479-24-000076.md","text":"https://secwatch.observer/filing/0000818479-24-000076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/0000818479-24-000076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/xray-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:47:01.476569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}